Quantcast
Tag archive for ‘Cubist Pharmaceuticals’
By Brandon Jones On Saturday, March 16th, 2019
1 Comment

Prescription drug prices falling to 47 year low as generics rise, Amy Klobuchar wrong on talking points

The cost of prescription drugs are falling for the first time in 47 years. photo/ Andrea The government on Tuesday said prescription prices sank 1% in February, marking the biggest one-month decline ever. The cost More...

By Guest Author On Friday, October 21st, 2016
2 Comments

The DEA, the Kratom ban and A March of a dedicated few

On August 30th Forbes published an article revealing the DEA’s plan to ban the herbal supplement known as kratom. The governmental agency stated that kratom poses “an imminent hazard to the public safety” More...

By The Dispatch On Monday, March 31st, 2014
2 Comments

Sivextro, to treat MRSA skin infections, receives recommendation from FDA Anti-Infective Drugs Advisory Committee

PRESS RELEASE Cubist Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) Anti-Infective Drugs Advisory Committee (AIDAC) voted to recommend approval of Cubist’s investigational More...

By The Dispatch On Monday, December 30th, 2013
0 Comments

FDA accepts Cubist’s NDA for the investigational antibiotic tedizolid to treat MRSA infections

PRESS RELEASE  Cubist Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted the Company’s New Drug Application (NDA) for its investigational antibiotic tedizolid More...


Recent Posts

August 19, 2019, Comments Off on

August 19, 2019, Comments Off on

August 18, 2019, Comments Off on

August 18, 2019, Comments Off on

DISPATCH BLOGS

Splash Page logo 300x146 Today in History